BioBridge Global
BioBridge Global is a nonprofit organization dedicated to saving and enhancing lives through the healing power of human cells and tissue. It operates a family of nonprofits including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and The Blood & Tissue Center Foundation. The organization provides lifesaving therapies to patients and supports advances in advanced therapies, focusing on blood, cell, and tissue products, testing services, and the development of new therapies.
Industries
N/A
Nr. of Employees
small (1-50)
BioBridge Global
6211 IH 10 West San Antonio, Texas 78201
Patents
Methods for performing miniaturized dynamic assays using microfluidics and related systems
US-12590952-B2
View Details
Methods for performing miniaturized dynamic assays using microfluidics and related systems
US-12590952-B2
View DetailsProducts
Blood components for transfusion
Clinical blood products including red blood cells, platelets, plasma and cryoprecipitate for hospital transfusion use.
Leukopaks and apheresis-derived starting materials
Autologous and allogeneic leukopaks and other apheresis collections provided fresh or cryopreserved with specified cell counts for downstream manufacturing.
Cord blood units (fresh or frozen)
Cord blood units collected, characterized and cryopreserved for transplant or research with unit selection by total nucleated cell count, volume or RBC content.
Perinatal and birth tissue products
Fresh or frozen perinatal tissues (umbilical cord, placenta, birth tissue) recovered, tested and provided for research or processing by tissue processors.
Cryopreserved grafts and tissue storage
Autologous tissue storage and provision of cryopreserved grafts for clinical surgical use (cardiac, vascular and other graft types).
Biomaterials and research-grade biospecimens
Access to research-grade biomaterials including PBMCs, whole blood derivatives, buffy coats and deceased donor tissues for research use.
Blood components for transfusion
Clinical blood products including red blood cells, platelets, plasma and cryoprecipitate for hospital transfusion use.
Leukopaks and apheresis-derived starting materials
Autologous and allogeneic leukopaks and other apheresis collections provided fresh or cryopreserved with specified cell counts for downstream manufacturing.
Cord blood units (fresh or frozen)
Cord blood units collected, characterized and cryopreserved for transplant or research with unit selection by total nucleated cell count, volume or RBC content.
Perinatal and birth tissue products
Fresh or frozen perinatal tissues (umbilical cord, placenta, birth tissue) recovered, tested and provided for research or processing by tissue processors.
Cryopreserved grafts and tissue storage
Autologous tissue storage and provision of cryopreserved grafts for clinical surgical use (cardiac, vascular and other graft types).
Biomaterials and research-grade biospecimens
Access to research-grade biomaterials including PBMCs, whole blood derivatives, buffy coats and deceased donor tissues for research use.
Services
Collection, mobile drives, manufacturing and supply of blood components to hospital partners with online ordering portal support.
Donor screening, microbiology, immunohematology reference testing and cellular therapy testing provided from accredited CLIA and AABB laboratories with automation capabilities.
cGMP biomanufacturing, process development and clinical production for cell and cell-based biologics with cleanroom facilities and regulatory support.
On-site R&D analytical services for assay development and qualification (safety assays, cell characterization, cytokine panels and PCR viral markers) with capabilities to move assays toward cGMP use.
Customized collection and supply of leukopaks, cord blood, birth tissue, PBMCs, whole blood products and deceased donor tissues with donor screening and documentation.
Recruitment, clinical clearance, accredited onsite testing, collection and shipment of apheresis-derived cellular materials to support trials and product development.
Collection, mobile drives, manufacturing and supply of blood components to hospital partners with online ordering portal support.
Donor screening, microbiology, immunohematology reference testing and cellular therapy testing provided from accredited CLIA and AABB laboratories with automation capabilities.
cGMP biomanufacturing, process development and clinical production for cell and cell-based biologics with cleanroom facilities and regulatory support.
On-site R&D analytical services for assay development and qualification (safety assays, cell characterization, cytokine panels and PCR viral markers) with capabilities to move assays toward cGMP use.
Customized collection and supply of leukopaks, cord blood, birth tissue, PBMCs, whole blood products and deceased donor tissues with donor screening and documentation.
Recruitment, clinical clearance, accredited onsite testing, collection and shipment of apheresis-derived cellular materials to support trials and product development.
Expertise Areas
- Blood collection and transfusion services
- Apheresis collections for cell therapy starting materials
- cGMP biomanufacturing and IND-phase support for cell therapies
- Analytical assay development, qualification and transfer to cGMP
Key Technologies
- Flow cytometry (multi-parameter panels)
- qPCR / nucleic acid testing (viral panels)
- Multiplex cytokine assays
- ELISA and immunoassays
News & Updates
On Jan. 2, 2023, Asante Contreras and 43 other donors across the nation were honored for their contributions.
BioBridge Global’s R&D Analytical Development team now has a specialized lab to call their own.
BioBridge Global CEO Martin Landon spoke on a panel during the Invest San Antonio 2023-2024 Conference, highlighting the organization's growing capabilities.
South Texas Blood & Tissue leaders were featured in a webinar on an innovative program to collect whole blood-derived platelets.
On Jan. 2, 2023, Asante Contreras and 43 other donors across the nation were honored for their contributions.
BioBridge Global’s R&D Analytical Development team now has a specialized lab to call their own.
BioBridge Global CEO Martin Landon spoke on a panel during the Invest San Antonio 2023-2024 Conference, highlighting the organization's growing capabilities.
South Texas Blood & Tissue leaders were featured in a webinar on an innovative program to collect whole blood-derived platelets.